Vagus nerve stimulation is a social-media sensation, promising instant stress relief. Here’s what the science really says ...

Primary central nervous system lymphoma (PCNSL) is a rare and highly aggressive lymphoma or tumor of the brain. While ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...

Booster Therapeutics, a biotechnology company pioneering a new class of proteasome activator medicines to treat neurodegenerative and other diseases, announced today it has received a research grant ...

Native American Heritage Month, Refugia of the Blue Mountains, Scrabble Club, A Shift in Thinking, Honk! Jr. — The Musical ...

Unapproved peptide drugs have become a trendy new hack among wellness influencers, fitness coaches and celebrities, pitched ...

Vistagen , a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called ...

Russia’s Kirov-Class Battlecruiser Reboot Has ‘Museum Piece’ Written All Over It -Russia is pouring billions of dollars and ...

The Librexia clinical trial program includes two other Phase 3 trials, Librexia AF for patients with atrial fibrillation (AF) and Librexia STROKE for secondary stroke prevention (SSP). The IDMC ...

Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society for Radiation ...

Heretic, debater, wife-snatcher, subject of a posthumous cult: Pico della Mirandola certainly had a wild career. In this smart and rangy book, Wilson-Lee, a Cambridge don, paints a glorious portrait ...

West Branch's Alli Kanagy is much more than a three-sport athlete. In mixing her varied interests, she also is a broadcaster ...